Amphastar P (AMPH)
Operating return on assets (Operating ROA)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 196,987 | 180,839 | 131,389 | 119,316 | 107,497 | 93,917 | 95,458 | 81,195 | 69,887 | 48,514 | 27,262 | 13,780 | 10,954 | 7,831 | 6,718 | 10,613 | -39 | 1,750 | 1,896 | -2,018 |
| Total assets | US$ in thousands | 1,512,910 | 1,544,630 | 1,378,270 | 773,656 | 741,987 | 726,695 | 723,719 | 716,238 | 671,529 | 651,677 | 665,745 | 645,738 | 631,236 | 613,718 | 600,058 | 572,831 | 586,971 | 585,636 | 601,301 | 544,718 |
| Operating ROA | 13.02% | 11.71% | 9.53% | 15.42% | 14.49% | 12.92% | 13.19% | 11.34% | 10.41% | 7.44% | 4.09% | 2.13% | 1.74% | 1.28% | 1.12% | 1.85% | -0.01% | 0.30% | 0.32% | -0.37% |
December 31, 2023 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $196,987K ÷ $1,512,910K
= 13.02%
To analyze Amphastar Pharmaceuticals Inc's operating return on assets (operating ROA), we can observe fluctuations in the ratio over the past 8 quarters:
- In Q4 2023, the operating ROA was 13.02%, showing a slight increase from the previous quarter.
- In Q3 2023, the operating ROA was 11.71%, marking a decrease from the preceding quarter.
- In Q2 2023, the operating ROA stood at 9.53%, reflecting a notable decline compared to the previous quarter.
- In Q1 2023, the operating ROA increased to 15.42%, indicating a significant improvement from the quarter before.
- Looking back at Q4 2022, the operating ROA was 14.49%, which was slightly lower compared to the most recent quarter.
- In Q3 2022, the operating ROA was 12.92%, followed by 13.19% in Q2 2022 and 11.34% in Q1 2022.
Overall, the operating ROA for Amphastar Pharmaceuticals Inc has shown fluctuations over the past eight quarters, with varying levels of performance. Investors and stakeholders may want to further investigate the factors contributing to these changes to assess the company's operational efficiency and profitability.
Peer comparison
Dec 31, 2023